Literature DB >> 19299738

Activation of microglia by amyloid {beta} requires P2X7 receptor expression.

Juana M Sanz1, Paola Chiozzi, Davide Ferrari, Marilena Colaianna, Marco Idzko, Simonetta Falzoni, Renato Fellin, Luigia Trabace, Francesco Di Virgilio.   

Abstract

Extracellular ATP is a mediator of intercellular communication and a danger signal. Release of this and other nucleotides modulates microglia responses via P2Y and P2X receptors, among which the P2X(7) subtype stands out for its proinflammatory activity and for up-regulation in a transgenic model of Alzheimer disease and in brains from Alzheimer disease patients. Here we show that amyloid beta (Abeta) triggered increases in intracellular Ca(2+) ([Ca(2+)](i)), ATP release, IL-1beta secretion, and plasma membrane permeabilization in microglia from wild-type but not from P2X(7)-deleted mice. Likewise, intra-hippocampal injection of Abeta caused a large accumulation of IL-1beta in wild-type but not in P2X(7)(-/-) mice. These observations suggest that Abeta activates a purinergic autocrine/paracrine stimulatory loop of which the P2X(7) receptor is an obligate component. Identification of the P2X(7) receptor as a non-dispensable factor of Abeta-mediated microglia stimulation may open new avenues for the treatment of Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299738     DOI: 10.4049/jimmunol.0803612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  96 in total

Review 1.  Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.

Authors:  Talita Glaser; Angélica Regina Cappellari; Micheli Mainardi Pillat; Isabele Cristiana Iser; Márcia Rosângela Wink; Ana Maria Oliveira Battastini; Henning Ulrich
Journal:  Purinergic Signal       Date:  2011-12-06       Impact factor: 3.765

Review 2.  Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.

Authors:  Davide Lecca; Stefania Ceruti; Marta Fumagalli; Maria P Abbracchio
Journal:  Purinergic Signal       Date:  2012-04-12       Impact factor: 3.765

Review 3.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

4.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

Review 5.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

6.  P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia.

Authors:  Hui-quan Li; Cong Chen; Ying Dou; Hang-jun Wu; Yi-jun Liu; Hui-Fang Lou; Jian-min Zhang; Xiao-ming Li; Hao Wang; Shumin Duan
Journal:  Mol Cell Biol       Date:  2013-09-03       Impact factor: 4.272

Review 7.  Role of microglia in neuronal degeneration and regeneration.

Authors:  Lisa Walter; Harald Neumann
Journal:  Semin Immunopathol       Date:  2009-09-09       Impact factor: 9.623

Review 8.  Neuronal P2X7 Receptors Revisited: Do They Really Exist?

Authors:  Peter Illes; Tahir Muhammad Khan; Patrizia Rubini
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

Review 9.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

10.  P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus.

Authors:  Ji-Eun Kim; Hea Jin Ryu; Seong-Il Yeo; Tae-Cheon Kang
Journal:  J Neuroinflammation       Date:  2010-10-12       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.